title: Kappa opioids and TGFbeta1 interact in human endometrial cells.
abstract: The transforming growth factor beta1 (TGFbeta1) is a major regulator of human endometrial function. Human endometrium possesses specific opioid binding sites, the majority of which belong to the kappa type, for which the prodynorphin-derived opioids are the endogenous ligands. Since these two systems interact in several other tissues we postulated that opioids may affect the production of TGFbeta1 in human endometrium. We have found that kappa opioids exerted a time- and dose-dependent inhibitory effect on TGFbeta1 production from endometrial stromal and epithelial cells and from the Ishikawa human endometrial adenocarcinoma cell line. This effect was reversible by the specific opioid antagonist diprenorphine. To examine if this effect represents a paracrine endometrial response to locally produced kappa opioids we searched for the presence of the endogenous kappa opioid receptor ligands. Indeed, the prodynorphin transcript was detectable on Northern blots from normal and tumoral human endometrial cells; its size was that of the pituitary transcript, i.e. approximately 2.4 kb long. Most immunoreactive dynorphin from human endometrium had a molecular weight of 8 kDa. Finally, immunofluorescence staining of normal and tumoral human endometrial cells revealed the presence of dynorphin-positive cytoplasmic secretory granules. Taken together, our data suggest that in human endometrium, kappa opioids and the TGFbeta1 form a paracrine network which appears to be retained by the Ishikawa human endometrial adenocarcinoma cell line.
authors.affiliation: Department of Pharmacology, Medical School, University of Crete, Heraklion GR-711 10, Crete, Greece.
authors.forename: E
authors.initials: E
authors.lastname: Chatzaki
authors.forename: A N
authors.initials: AN
authors.lastname: Margioris
authors.forename: A
authors.initials: A
authors.lastname: Makrigiannakis
authors.forename: E
authors.initials: E
authors.lastname: Castanas
authors.forename: V
authors.initials: V
authors.lastname: Georgoulias
authors.forename: A
authors.initials: A
authors.lastname: Gravanis
mesh_terms: D002478:Cells, Cultured; D004174:Diprenorphine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004717:Endometrium / Q000378:metabolism*; D004745:Enkephalins / Q000378:metabolism / Q000494:pharmacology*; D005260:Female; D006801:Humans; D009294:Narcotics / Q000378:metabolism / Q000494:pharmacology; D011498:Protein Precursors / Q000378:metabolism / Q000494:pharmacology*; D017473:Receptors, Opioid, kappa / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D016212:Transforming Growth Factor beta / Q000378:metabolism*
chemical_list: D004745:Enkephalins; D009294:Narcotics; D011498:Protein Precursors; D017473:Receptors, Opioid, kappa; D016212:Transforming Growth Factor beta; D004174:Diprenorphine; C033660:preproenkephalin